CRYSTAL-STRUCTURE OF A DOMINANT B-CELL EPITOPE FROM THE PRES2 REGION OF HEPATITIS-B VIRUS IN THE FORM OF AN INSERTED PEPTIDE SEGMENT IN MALTODEXTRIN-BINDING PROTEIN
Fa. Saul et al., CRYSTAL-STRUCTURE OF A DOMINANT B-CELL EPITOPE FROM THE PRES2 REGION OF HEPATITIS-B VIRUS IN THE FORM OF AN INSERTED PEPTIDE SEGMENT IN MALTODEXTRIN-BINDING PROTEIN, Journal of Molecular Biology, 280(2), 1998, pp. 185-192
We report here the crystal structure of MalE-B363, a recombinant const
ruction of maltodextrin-binding protein bearing a dominant B-cell epit
ope sequence from the preS2 region of the hepatitis B surface antigen.
The inserted peptide sequence, which replaces the seven carboxy-termi
nal residues of maltodextrin-binding: protein, carries the 14 amino ac
id residue epitope contained between residues 132 and 145 from the pre
S2 region. The epitope sequence is flanked on either side by additiona
l residues that result from the genetically engineered insertion, brin
ging the total length of the foreign peptide to 26 amino acid residues
. The hybrid protein has been previously shown to be recognised by mon
oclonal antibodies elicited by the native viral antigen. Three indepen
dent molecules of MalE-B363 are present in the asymmetric unit of the
crystal. All 14 epitope residues could be traced for one molecule, ten
epitope residues had significant electron density for the second, but
no density was visible for the epitope of the third. The conformation
of the amino-terminal segment of the epitope from Gln132(e) to Gly138
(e) is similar in the two molecules of MalE-B363 for which the foreign
peptide could be traced. Moreover, the conformation of a smaller segm
ent, comprising residues Asp133(e) to Arg137(e), is similar to that pr
esent in the previously determined crystal structure of MalE-B133, ano
ther insertion/deletion mutant of maltodextrin-binding protein bearing
the preS2 epitope. The presence of a common structural motif for the
same sequence in disparate molecular environments suggests that this c
onformation might be present also in the native viral antigen. This co
uld provide a structural basis to explain the cross-reactivity of anti
-preS2 monoclonal antibodies with these hybrid proteins. (C) 1998 Acad
emic Press.